Novo Nordisk (NYSE:NVO) shares have dropped by close to 4% this week, shedding more than £350 billion from its market cap, after a study suggested there may be a link between its blockbuster weight loss drugs Wegovy and Ozempic and vision loss.
Those who have been prescribed the weight-loss injection are at a higher risk of developing an eye condition linked to blindness, the study said.
Multinational advertising giant WPP PLC (LSE:WPP)’s second-quarter results are due on 7 August, with analysts pinning hopes on signs of recovery following a dour 12 months.
Advertising spend has been a net loser amid the global inflation cycle, but with cost pressures coming down and interest rates soon to follow, WPP could soon be seeing green shoots.
Britain’s two largest clay brick manufacturers are in line to rebound following the election analysts at Canadian bank RBC believe.
Ibstock PLC (LSE:IBST) and Forterra PLC (LSE:FORT) have been knocked by the slowdown in UK housebuilding, causing demand for clay bricks to fall to levels not seen since the global financial crisis.
The new Great Portland Estates (LSE:GPOR) £350 million equity raise comes at just the right time to capitalise on the central London property market’s cyclical upswing.
That’s according to Shore Capital Markets’ analysis of the property investor’s third-quarter trading update published today.
Spectris PLC (LSE:SXS) shares shot higher after it struck a deal to buy US-based SciAps, which provides what it calls "laser-based guns" for materials analysis.
The FTSE 250 group has agreed to pay US$260 million, of which US$200 million is upfront.